ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Localized Prosate Cancer Patients Should Receive TRT Following Treatment
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 78234" data-attributes="member: 2624"><p>A urologist at Queen's University, Kingston, Ontario, Canada, argues in a recent edition of "European Focus: Urology," <strong>"that a hypogonadal man with successfully treated <u><em>localized prostate cancer</em></u> deserves testosterone therapy (TTh/TRT) regardless of grade. The evidence is not conclusive but compelling. The story is different for those with intermediate-risk disease who, for a variety of reasons, need TTh/TRT but cannot or elect not to have treatment of their primary malignancy, but still desire androgen supplementation."</strong></p><p></p><p>The situation for a man who finds he is dealing with intermediate risk prostate cancer is somewhat more complex. However, even men in that situation should be evaluated according to the criteria in the table presented below to determine if TRT is appropriate.</p><table class='post-table ' style='width: 100%'><tr><td ><ul> <li data-xf-list-type="ul"><strong>Competent, qualified, and interested treating physician</strong></li> </ul></td></tr><tr><td ><ul> <li data-xf-list-type="ul"><strong>Patient able and willing to provide informed consent</strong></li> </ul></td></tr><tr><td ><ul> <li data-xf-list-type="ul"><strong>Clinical picture compatible with diagnosis of significant testosterone deficiency</strong></li> </ul></td></tr><tr><td ><ul> <li data-xf-list-type="ul"><strong>Serum testosterone levels supporting the diagnosis of testosterone deficiency</strong></li> </ul></td></tr><tr><td ><ul> <li data-xf-list-type="ul"><strong>Gleason grade group <2&#8211;3</strong></li> </ul></td></tr><tr><td ><ul> <li data-xf-list-type="ul"><strong>Disease confined to the pelvis (stage <T2c)</strong></li> </ul></td></tr><tr><td ><p> <ul> <li data-xf-list-type="ul"><strong>Absence of contraindications (erythrocytosis, sleep apnea, congestive heart failure)</strong></li> </ul><p><strong></strong><br /> <strong><a href="http://www.eu-focus.europeanurology.com/article/S2405-4569(17)30161-X/fulltext" target="_blank">http://www.eu-focus.europeanurology.com/article/S2405-4569(17)30161-X/fulltext</a></strong><br /> <strong></strong><br /> <strong></strong>This yet another voice calling for doctors and surgeons to reconsider the long-standing aversion many have toward testosterone therapy for prostate cancer patients. The belief that TRT is absolutely contraindicated can no longer be supported.</p></td></tr></table></blockquote><p></p>
[QUOTE="CoastWatcher, post: 78234, member: 2624"] A urologist at Queen's University, Kingston, Ontario, Canada, argues in a recent edition of "European Focus: Urology," [B]"that a hypogonadal man with successfully treated [U][I]localized prostate cancer[/I][/U] deserves testosterone therapy (TTh/TRT) regardless of grade. The evidence is not conclusive but compelling. The story is different for those with intermediate-risk disease who, for a variety of reasons, need TTh/TRT but cannot or elect not to have treatment of their primary malignancy, but still desire androgen supplementation."[/B] The situation for a man who finds he is dealing with intermediate risk prostate cancer is somewhat more complex. However, even men in that situation should be evaluated according to the criteria in the table presented below to determine if TRT is appropriate. [TABLE] [TR] [TD] [LIST] [*][B]Competent, qualified, and interested treating physician[/B] [/LIST] [/TD] [/TR] [TR] [TD] [LIST] [*][B]Patient able and willing to provide informed consent[/B] [/LIST] [/TD] [/TR] [TR] [TD] [LIST] [*][B]Clinical picture compatible with diagnosis of significant testosterone deficiency[/B] [/LIST] [/TD] [/TR] [TR] [TD] [LIST] [*][B]Serum testosterone levels supporting the diagnosis of testosterone deficiency[/B] [/LIST] [/TD] [/TR] [TR] [TD] [LIST] [*][B]Gleason grade group <2–3[/B] [/LIST] [/TD] [/TR] [TR] [TD] [LIST] [*][B]Disease confined to the pelvis (stage <T2c)[/B] [/LIST] [/TD] [/TR] [TR] [TD] [LIST] [*][B]Absence of contraindications (erythrocytosis, sleep apnea, congestive heart failure)[/B] [/LIST] [B] [URL]http://www.eu-focus.europeanurology.com/article/S2405-4569(17)30161-X/fulltext[/URL] [/B]This yet another voice calling for doctors and surgeons to reconsider the long-standing aversion many have toward testosterone therapy for prostate cancer patients. The belief that TRT is absolutely contraindicated can no longer be supported.[/TD] [/TR] [/TABLE] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Localized Prosate Cancer Patients Should Receive TRT Following Treatment
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top